Apogee Therapeutics (APGE) Interest Coverage Ratio (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Interest Coverage Ratio data on file, last reported at 0.31 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 99.98% year-over-year to 0.31 in Q1 2026; TTM through Mar 2026 was 1.14, a 99.98% increase from a year earlier, with the FY2025 full-year figure at 1.32, up 53.65% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.31, up from 0.36 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for APGE reached as high as 0.31 in Q1 2026 and fell as low as 1603.66 in Q1 2025.
• Historically, Interest Coverage Ratio has averaged 262.6 across 5 years, with a median of 1.45 in 2025.
• Across the five-year window, Interest Coverage Ratio slumped 485832.35% in 2025 and soared 99.98% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 2.11 in 2022, then surged by 41.64% to 1.23 in 2023, then fell by 0.2% to 1.23 in 2024, then surged by 70.73% to 0.36 in 2025, then gained by 14.52% to 0.31 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.31 in Q1 2026, 0.36 in Q4 2025, and 1.62 in Q3 2025.